Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors


Creative Commons License

ACER E., KAYA ERDOĞAN H., Canakci N. Y. , SARAÇOĞLU Z. N.

CUTANEOUS AND OCULAR TOXICOLOGY, vol.39, no.2, pp.171, 2020 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 39 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.1080/15569527.2020.1743304
  • Journal Name: CUTANEOUS AND OCULAR TOXICOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Environment Index, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.171
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

We read Cosansu's commentary entitled "Effectiveness of the new inflammatory parameters in patients with chronic spontaneous urticarial" to our study with great interest. The author remarked that a limited number of patients had C-reactive protein levels and it was not specified whether there were any other drugs used by the patients and no information was given about the severity of the disease in our study.